International Clinical Trial: Phase 1 Study of CLIP-100 in Healthy Adults

Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ACTRN12626000483358) titled 'Phase 1 Study of CLIP-100 in Healthy Adults' on April 17.

Study Type: Interventional

Study Design: Purpose: Treatment Allocation: Randomised controlled trial Masking: Blinded (masking used)

Primary Sponsor: Amalfi Bio, Inc

Condition: Localized Subcutaneous Fat (Abdominal) Localized Subcutaneous Fat (Abdominal) Skin - Other skin conditions

Intervention: This is a dose-escalation study evaluating five single ascending dose cohorts of CLIP-100 (60mg, 120mg, 240mg, 300mg, 400mg). A single dose will be administered by subcutaneous injection into the abdominal adipose tissue by clinical staff at the Phase 1 ...